ResMed tipping a U-shaped recovery out of COVID-19
Key Points
- Revenue ($USm) 2957.0, up 13.4%
- Pre-tax profit ($USm) 733.1, up 41.3%
- Net profit ($USm) 621.7, up 53.7%
- Q4 dividend 39c, flat - payable on Sept 24
ResMed boss Mick Farrell is tipping a U-shaped recovery out of COVID-19 and says he is feeling "pretty bullish" on the medical device maker returning to pre-virus operations within 12 to 24 months.
San Diego-based Mr Farrell told The Australian Financial Review while different nations will have their own road maps to reopen society, people are feeling more confident about seeing doctors and sleep specialists, including the use of more telehealth.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles